Exponent, Inc. (NASDAQ:EXPO) Shares Acquired by Argent Capital Management LLC

Argent Capital Management LLC lifted its position in Exponent, Inc. (NASDAQ:EXPO) by 5.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,150 shares of the business services provider’s stock after purchasing an additional 1,298 shares during the period. Argent Capital Management LLC’s holdings in Exponent were worth $2,784,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in shares of Exponent by 5.8% in the 1st quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock valued at $437,153,000 after purchasing an additional 291,047 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC raised its stake in shares of Exponent by 6.5% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider’s stock worth $441,414,000 after buying an additional 284,179 shares during the period. Conestoga Capital Advisors LLC lifted its position in shares of Exponent by 2.8% during the 2nd quarter. Conestoga Capital Advisors LLC now owns 2,763,260 shares of the business services provider’s stock valued at $262,841,000 after buying an additional 75,909 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in Exponent by 0.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,019,085 shares of the business services provider’s stock valued at $96,937,000 after acquiring an additional 6,108 shares during the period. Finally, Bank of New York Mellon Corp increased its holdings in Exponent by 3.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 534,520 shares of the business services provider’s stock worth $50,844,000 after acquiring an additional 17,849 shares in the last quarter. 92.37% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Truist Financial restated a “buy” rating and set a $120.00 price objective (up from $100.00) on shares of Exponent in a research report on Friday, July 26th.

Insider Buying and Selling at Exponent

In other Exponent news, VP John Pye sold 3,956 shares of the business’s stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $105.00, for a total value of $415,380.00. Following the transaction, the vice president now directly owns 28,422 shares in the company, valued at $2,984,310. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 2.10% of the stock is owned by company insiders.

Exponent Trading Down 0.4 %

NASDAQ:EXPO traded down $0.46 during trading hours on Thursday, hitting $106.63. 31,367 shares of the stock were exchanged, compared to its average volume of 245,536. Exponent, Inc. has a 52-week low of $64.61 and a 52-week high of $115.75. The company has a market cap of $5.41 billion, a P/E ratio of 54.09 and a beta of 0.66. The firm’s fifty day moving average price is $109.14 and its 200 day moving average price is $99.87.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.57 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.07. The company had revenue of $132.43 million during the quarter, compared to the consensus estimate of $130.83 million. Exponent had a net margin of 19.35% and a return on equity of 28.39%. Exponent’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.50 EPS. Equities analysts expect that Exponent, Inc. will post 2.04 EPS for the current fiscal year.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.